Dr Stefan Ryser joins Telik
This article was originally published in Scrip
Executive Summary
Dr Stefan Ryser has been appointed to the newly created position of senior vice-president of corporate strategy at Telik (US). He has more than 20 years' executive and investment experience in the biotechnology and pharmaceutical industries, including 10 years as an independent Telik director. Dr Ryser most recently served as founding and managing partner of Bear Stearns Health Innoventures.
You may also be interested in...
Xbrane Assembles The Troops As FDA Says No To Lucentis Biosimilar
Xbrane Biopharma was riding the crest of a wave with the EU launch of its biosimilar to Lucentis, following years of toil and investment. However, plans to roll out the product in the US will have to be pushed back – likely – into the middle of 2025, following a US FDA complete response letter.
UK MHRA Updates Assistive Tech And Borderline Regulations
Device classification themes were uppermost in April for the UK regulator, which issued key guidance in two areas prone to complexities. It also contributed to the MedTech Directorate’s one-year progress report.
Fujifilm Demonstrates Health Specialism With European HealthTech Spinout
From X-ray film in 1936 to the world’s first digital X-ray system in 1983, Fujifilm has a long heritage in medical diagnostics.